Pharma & Biotech
BioPorto focused on flagship NGAL acute kidney-injury test but also looking at coronavirus test
Helix BioPharma advancing efforts to combat killer cancers with unique immuno-oncology therapies
Orgenesis leads the charge at an exciting time for cell and gene therapy
Only registered members can use this feature.
Copyright © Proactive 2021.
All Rights Reserved - Proactive North America Inc., Proactive Investors LLC.